Purdue Pharma owners up opioid settlement offer to $6 bn
COVID-19 survivors face increased mental health risks up to a year later
19 February 2022UK: People with COVID in England won’t need to self-isolate
20 February 2022Purdue Pharma owners up opioid settlement offer to $6 bn
The owners of Purdue Pharma, maker of OxyContin, have offered to pay up to $6 billion to victims of the US opioid crisis to settle an avalanche of litigation, according to a report filed Friday by a federal mediator.
